Sensitization-based risk for substance abuse in vulnerable individuals with ADHD: Review and re-examination of evidence

Neurosci Biobehav Rev. 2022 Apr:135:104575. doi: 10.1016/j.neubiorev.2022.104575. Epub 2022 Feb 10.

Abstract

Evidence of sensitization following stimulants administration in humans is just emerging, which prevents reaching more definitive conclusions in favor or against a purported protective role of stimulant treatments for ADHD for the development of substance use disorders. Existing evidence from both animal and human research suggest that stimulants produce neurophysiological changes in the brain reward system, some of which could be persistent. This could be relevant in choosing optimal treatments for young patients with ADHD who have additional clinical risk factors for substance abuse (e.g. conduct disorder (CD) and/or familial addictions). Here we stipulate that, while the majority of youth with ADHD greatly benefit from treatments with stimulants, there might be a subpopulation of individuals whose neurobiological profiles may confer risk for heightened vulnerability to the effects of stimulants on the responsiveness of the brain reward system. We propose that focused human research is needed to elucidate the unknown effects of prolonged stimulant exposure on the neurophysiology of the brain reward system in young patients with ADHD.

Keywords: ADHD; Brain reward system; SUD; Sensitization; Stimulants.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Attention Deficit Disorder with Hyperactivity* / drug therapy
  • Central Nervous System Stimulants* / therapeutic use
  • Conduct Disorder* / drug therapy
  • Humans
  • Risk Factors
  • Substance-Related Disorders* / therapy

Substances

  • Central Nervous System Stimulants